UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

Guidelines for the welfare and use of animals in cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1555-1577

2010

Link zum Volltext

Verfügbarkeit prüfen

Rituximab: mechanisms and applications

British journal of cancer, 2001-11, Vol.85 (11), p.1619-1623

2001

Link zum Volltext

Verfügbarkeit prüfen

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

The Journal of immunology (1950), 2000-11, Vol.165 (10), p.5954-5961

2000

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 phase I trial

Cancer immunology research, 2014-03, Vol.2 (3), p.229-240

2014

Link zum Volltext

Verfügbarkeit prüfen

EPIDERMAL GROWTH FACTOR RECEPTOR AND G250: USEFUL TARGET ANTIGENS FOR ANTIBODY MEDIATED CELLULAR CYTOTOXICITY AGAINST RENAL CELL CARCINOMA?

The Journal of urology, 2002-02, Vol.167 (2), p.707-712

2002

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors

The Journal of immunology (1950), 1998-09, Vol.161 (6), p.3176-3185

1998

Link zum Volltext

Verfügbarkeit prüfen

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

Nature medicine, 1999-05, Vol.5 (5), p.548-553

1999

Link zum Volltext

Verfügbarkeit prüfen

Complement mediated cell death is associated with DNA fragmentation

Cell death and differentiation, 2000-01, Vol.7 (1), p.48-58

2000

Link zum Volltext

Verfügbarkeit prüfen

Saporin, a ribosome‐inactivating protein used to prepare immunotoxins, induces cell death via apoptosis

British journal of haematology, 1996-06, Vol.93 (4), p.789-794

1996

Link zum Volltext

Verfügbarkeit prüfen

HLA Class II as Potential Target Antigen on Malignant B Cells for Therapy With Bispecific Antibodies in Combination With Granulocyte Colony-Stimulating Factor

Blood, 1996-05, Vol.87 (9), p.3803-3812

1996

Link zum Volltext

Verfügbarkeit prüfen

Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments

The Journal of immunology (1950), 1987-10, Vol.139 (7), p.2367

1987

Link zum Volltext

Verfügbarkeit prüfen

The Importance of Antibody-Specificity in Determining Successful Radioimmunotherapy of B-Cell Lymphoma

Blood, 1999-07, Vol.94 (1), p.233-243

1999

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells

British journal of cancer, 1999-02, Vol.79 (5-6), p.850-857

1999

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD20 monoclonal antibodies: historical and future perspectives

Haematologica (Roma), 2010-01, Vol.95 (1), p.135-143

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154

European journal of immunology, 2001-10, Vol.31 (10), p.3094-3100

2001

Link zum Volltext

Verfügbarkeit prüfen

Signaling antibodies in cancer therapy

Current Opinion in Immunology, 1999-10, Vol.11 (5), p.541-547

1999

Link zum Volltext

Verfügbarkeit prüfen

Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma

The Journal of immunology (1950), 1995-07, Vol.155 (2), p.925

1995

Link zum Volltext

Verfügbarkeit prüfen

Production and characterization of monoclonal antibodies specific for human mast cell tryptase

Clinical and experimental allergy, 1990-09, Vol.20 (5), p.581-589

1990

Link zum Volltext

Verfügbarkeit prüfen

Response of B-cell lymphoma to a combination of bispecific antibodies and saporin

Leukemia research, 1996-07, Vol.20 (7), p.607-617

1996

Link zum Volltext

Verfügbarkeit prüfen

Delivery of saporin to human B-cell lymphoma using bispecific antibody : targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing

Cancer research (Chicago, Ill.), 1993-07, Vol.53 (13), p.3015-3021

1993

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide

Journal of immunological methods, 2001-06, Vol.252 (1), p.83-92

2001

Link zum Volltext

Verfügbarkeit prüfen

Signalling antibodies for the treatment of neoplastic disease

Disease markers, 2000, Vol.16 (1-2), p.63-63

Glennie, M J

2000

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, conformational properties, and antibody recognition of peptides containing .beta.-turn mimetics based on .alpha.-alkylproline derivatives

Journal of medicinal chemistry, 1991-06, Vol.34 (6), p.1777-1789

1991

Link zum Volltext

Verfügbarkeit prüfen

Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome

Cancer Immunology, Immunotherapy, 1997-11, Vol.45 (3-4), p.171-173

1997

Link zum Volltext

Verfügbarkeit prüfen

Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin

The Lancet (British edition), 1995-07, Vol.346 (8969), p.223-224

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(135)
Humans
(112)
Animals
(83)
Biological And Medical Sciences
(66)
Mice
(59)
Medical Sciences
(53)
Immunology
(50)
Immunotherapy
(48)
Antibodies, Monoclonal - Therapeutic Use
(32)
Hematology
(30)
Oncology
(30)
Antibodies, Monoclonal - Immunology
(29)
Pharmacology. Drug Treatments
(27)
Antineoplastic Agents
(26)
Female
(25)
Male
(25)
Mice, Inbred Balb C
(25)
Hematologic And Hematopoietic Diseases
(22)
Lymphoma, B-Cell - Immunology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the welfare and use of animals in cancer research

Rituximab: mechanisms and applications

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

Ex vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 phase I trial

EPIDERMAL GROWTH FACTOR RECEPTOR AND G250: USEFUL TARGET ANTIGENS FOR ANTIBODY MEDIATED CELLULAR CYTOTOXICITY AGAINST RENAL CELL CARCINOMA?

Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

Complement mediated cell death is associated with DNA fragmentation

Saporin, a ribosome‐inactivating protein used to prepare immunotoxins, induces cell death via apoptosis

HLA Class II as Potential Target Antigen on Malignant B Cells for Therapy With Bispecific Antibodies in Combination With Granulocyte Colony-Stimulating Factor

Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments

The Importance of Antibody-Specificity in Determining Successful Radioimmunotherapy of B-Cell Lymphoma

Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells

Anti-CD20 monoclonal antibodies: historical and future perspectives

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154

Signaling antibodies in cancer therapy

Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma

Production and characterization of monoclonal antibodies specific for human mast cell tryptase

Response of B-cell lymphoma to a combination of bispecific antibodies and saporin

Delivery of saporin to human B-cell lymphoma using bispecific antibody : targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide

Signalling antibodies for the treatment of neoplastic disease

Synthesis, conformational properties, and antibody recognition of peptides containing .beta.-turn mimetics based on .alpha.-alkylproline derivatives

Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome

Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin

Suchergebnisse filtern